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To determine trends in the microbial etiol- 
ogy of nosocomial infections in the 198Os, 
surveillance data on the microbiology of 
documented nosocomial infection reported 
to the National Nosocomial Infections Sur- 
veillance System and from the University of 
Michigan Hospital were analyzed. AnCmi- 
crobial susceptibility data on selected 
pathogens from both sources were also re- 
viewed. Overall, Escherichia coli decreased 
from 23% of infections in 1980 to 16% in 
1986-1989, Klebsiella pneumoniae dropped 
from 7% to 5%, whereas coagulase negative 
staphylococci increased from 4% to 9% and 
Candida albicans increased from 2% to 5%. 
Staphylococcus aureus, Pseudomonas aeru- 
ginosa, Enterobacter species and entero- 
cocci had minor increases, but antimicro- 
bial resistant strains for these pathogens as 
well as coagulase-negative staphylococci 
were seen more frequently. In contrast to 
the 197Os, major shifts in the etiology of 
nosocomial infection have occurred in the 
decade of the 1980s. Taken as a whole, the 
shifts are away from more easily treated 
pathogens toward more resistant pathogens 
with fewer options for therapy. These shifts 
underscore the continued need for preven- 
tion and control to accompany new develop- 
ments in therapy. 
From the Division of Infectious Diseases, Department of Internal Medicine, 
and Ann Arbor Veterans Administration Medical Center, University of 
Michigan Medical Center, Ann Arbor, Michigan, and Hospital Infections 
Program, Centers for Disease Control, Atlanta, Georgia. 
Reprint requests should be addressed to Dennis R. Schaberg, M.D., 
University of Michigan Medical Center, 3110 Taubman Center, Box 
0368, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109- 
0368. 
N osocomial infection remains a significant con- sequence of hospitalization. Estimates are 
that from 3% to 5% of patients leave the hospital 
having acquired infection, depending on case mix, 
hospital size, and multiple other factors [ll. Exam- 
ination of the microbial etiology of these infections 
provides important information in day-to-day deci- 
sion making in individual hospitals regarding poten- 
tial outbreaks, unusual pathogens, antimicrobial 
resistance, and local trends in the etiology of 
infection. It is also useful periodically to examine 
trends in the etiology of infection over more pro- 
longed time periods to detect shifts in the cause of 
infection. This report uses two sources of data, 
pooled data from participants in the National 
Nosocomial Infections Surveillance (NNIS) Sys- 
tem of the Centers for Disease Control (CDC) and 
single hospital data from a large tertiary referral 
teaching hospital, the University of Michigan Hos- 
pital, to examine trends in etiology of hospital- 
acquired infection in the decade of the 1980s. 
METHODS 
The NNIS system was established in January 
1970 and is currently the only nationwide source of 
information on nosocomial infections in the United 
States [2,31. This report examines surveillance 
among NNIS hospitals performing hospital-wide 
surveillance from 1980 to 1989. Patients were 
monitored for all nosocomial infections at all body 
sites. Standardized definitions for infection are 
provided to the participating hospitals [4] but a 
variety of case-finding methods were used. Various 
methods for performing antimicrobial susceptibili- 
ties, including disk diffusion, macrobroth, and 
microdilution are used, but each hospital must 
provide evidence of proficiency in the method being 
used. Data from each hospital are submitted 
monthly to the CDC. 
The percentage of coagulase-negative staphylo- 
cocci that were reported to be resistant to methicil- 
lin, oxacillin, or nafcillin (MRSE) was determined 
by estimating the mean percentage for 1989 for all 
hospitals that reported data. Hospitals that did not 
report susceptibility results for at least 20 coagu- 
lase-negative staphylococci in the year were ex- 
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TABLE I 
Pathogen Distribution for Major Sites of Nosocomial Infection, National Nosocomial Infections Surveillance System, 1986-1989 
I Pathogen Urinary Tract Infection Wound Pneumonia Bloodstream Total 
E. cob 
Enterococci 
P. aeruginosa 
S. aureis 
Coagulase negative staphylococci 
Enterobacter sp. 
K. pneumoniae 
C. albicans 
P. mirabilis 
Streptococcal species 
Citrobacter sp. 
Candida sp. 
S. marcescens 
11.135 1x)* 1,951 (10) 946 (6) 733 (6) 14,765 (16) 
2,645 (13) 342 (2) 1,037 (8) 10,744 (12) 
1,668 (8) 2,598 (17) 543 (4) 9,936 (11) 
2.401 (16) 1.984 (16) 8.647 (10) 
6,720 (16) 
5,:;; I;;’ 
1,634 (4) 
% IEi 
‘2’;;; I;; 
‘207 (0) 
812 (2) 
3,439 (17) 
y; ;;;I 
‘k 1;; 
712 (4) 
539 (3) 
“Ei Iii 
271 (1) 
1,625 iii 
1,;;; I;,’ 
503 (3) 
Et; ii i 
109 (1) 
579 (4) 
548 (4) 
617 (5) 
105 (1) 
465 (4) 
82 (1) 
330 (3) 
152 (1) 
‘) 7;783 (9, 
6,103 (7) 
4,872 (5) 
4,691 (5) 
EZ Id 
11441 (2) 
1,373 (2) 
1,369 (2) 
*Number (percent). Note: a site may have up to four pathogens. 
eluded from the analysis. Changes in percent of 
MRSE between two consecutive years were esti- 
mated using only the data from hospitals that 
reported to NNIS in both years. In this way, the 
estimated change in percent MRSE over the period 
1980-1989 was not biased by the effects of sample 
migration, i.e., hospitals joining and leaving NNIS. 
The University of Michigan Hospital is a 588 bed 
adult medical and surgical tertiary care hospital. 
Separate hospitals house the obstetrics service, the 
neonatal unit, and pediatric patients, which are 
not included in the data in this report. Definitions 
for nosocomial infection identical to those in NNIS 
are used [4]. Antimicrobial susceptibilities are 
performed by microbroth dilution. 
RESULTS 
When the overall pathogen distribution for the 
four major sites of hospital-acquired infections 
reported to NNIS from 1986-1989 is examined, 
Escherichia coli remains the most common isolate 
(Table I). The other pathogens accounting for 
greater than 10% of infections are enterococci, 
Pseudomonas aeruginosa, and Staphylococcus au- 
reus. These same four pathogens also dominate at 
the University of Michigan Hospital but the order 
differs slightly, E. coli also is most common, ac- 
counting for 23% of infections, but P. aeruginosa is 
second at 20% followed by the other two. Although 
E. coli still is the most frequent isolate, it has 
dropped in overall frequency comparing NNIS data 
from 1980 with 1986-1989 (Figure 1). Two of the 
top 10 pathogens have dropped in percentage, E. 
coli from 23% to 16% and Klebsiella pneumoniae 
from 7% to 5% of isolates. In contrast, coagulase- 
negative staphylococci have increased from 4% to 
9%, almost all as a function of increase in blood- 
stream infections. Candida albicans also increased 
from 2% in 1980 to 5% in 1986-1989, with the 
increase occurring across all major sites of infec- 
tion. Slight increases have occurred with S. au- 
reus, P. aeruginosa, enterococci and Enterobacter 
species, with the overall change of l-2% in each 
instance. 
In addition to the overall changes noted, there 
have been changes as well within a given genus, in 
particular in antimicrobial resistance phenotype. 
For example, 1982 was the first full year of suscep- 
tibility data for cefotaxime at the University of 
Michigan with 91% of isolates of P. aeruginosa 
susceptible in contrast to only 65% in 1989 and 
93% of Enterobacter cloacae susceptible in 1982 
versus 76% in 1989. Similarly, 97% of P. aerugi- 
nosa were sensitive to gentamicin in 1982 versus 
88% in 1989. Changes in phenotype in the gram- 
positive nosocomial pathogens have been seen as 
well. At the University of Michigan, in 1980 less 
than 1% of S. aureus isolates were methicillin- 
resistant, but in 1989 17% were resistant. In 1981, 
a single clinical isolate of high-level gentamicin- 
resistant enterococci was identified in our hospital. 
In 1989, 20% of all enterococcal isolates displayed 
this phenotype. Currently, more than 60% of coag- 
ulase-negative staphylococci at the University hos- 
pital are methicillin-resistant. This increasing resis- 
tance is also reflected in the pooled data from NNIS 
(Figure 2). 
COMMENTS 
Surveillance, including bacteriologic surveil- 
lance to provide background information in order 
to recognize nosocomial infection problems requir- 
ing control measures or interventions, remains 
important to current infection control efforts in 
hospitals. As has been noted by Stamm and cowork- 
ers [5], the bacteriology of epidemic nosocomial 
infection is dramatically different from endemic 
infection. The trends noted in this report pool 
bacteriology from both types of infections but 
endemic infections overwhelm any impact of out- 
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Figure 2. Proportion of coagulase-negative staphylococci from the 
National Nosocomial Infections Surveillance System reported as 
resistant to methicillin, oxacillin, or nafcillin, 1980-1989 
(n = 27,150). 
breaks. The changes noted thus appear to be 
gradual shifts in the pathogens isolated from hospi- 
tal-acquired infection. It should be noted that 
these shifts are in contrast to similar analysis over 
the last decade where no secular or periodic trends 
were found 161. 
One explanation for the shifts noted would be 
selective prevention of infections due to E. coli and 
K. pneumoniae. These organisms do share in com- 
mon a similar reservoir, the gastrointestinal tract, 
and endogenous acquisition as mode of infection. 
Figure 1. Comparative percentage of 
pathogen distribution for nosocomial 
infections, National Nosocomial Infec- 
tions Surveillance System, 1980 (white 
bars) versus 1986-89 (black bars). 
UTI = urinary tract infection. 
Antimicrobial prophylaxis or therapy with agents 
active against these organisms but not more resis- 
tant organisms, such as Enterobacter species, if 
used widely might explain the shift away from 
them as causes of infection. An antimicrobial 
group with such a spectrum is the so-called first- 
generation cephalosporins, which are often chosen 
as prophylaxis for a variety of procedures in hospi- 
tals, but whether this explains the observed shift 
away from Klebsiella and E. coli is speculation. 
Another major change is the increasing impor- 
tance of coagulase-negative staphylococci. This 
change is almost entirely due to the increase in 
bloodstream infection. This may in part be due to 
the growing appreciation of this organism as a 
pathogen 171 and thus a willingness to report 
positive cultures as true infections. It also may in 
part be due to the increasing reliance on a variety 
of devices, especially intravascular devices, to aid 
in the care of seriously ill hospital patients. A 
report by Gaynes et al [21 examines this secular 
trend. 
The most disturbing trend occurring in the 
1980s was a move away from more susceptible 
toward more resistant pathogens. This occurred 
both between and within genera. Genera that tend 
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to be more susceptible to antimicrobials, Proteus 
mirabilis, E. coli, and K. pneumoniae, all decreased 
in prevalence, whereas Enterobacter, Pseudomo- 
nas, Enterococcus, and Candida increased. Within 
genera, traditional etiologies in some instances 
changed little, but phenotype did. Several studies 
have already pointed out the growing problem of 
methicillin resistance in S. aureus [8,9] and similar 
changes in coagulase-negative staphylococci were 
found in this analysis. The abrupt increase in the 
proportion of coagulase-negative staphylococci re- 
sistant to semisynthetic penicillins in 1986 is likely 
the result of changes in recommended testing 
methodologies [lo], but the trend upward was 
clear both before and after these recommenda- 
tions. High-level gentamicin-resistant enterococci 
are a new and prominent nosocomial infection in 
some hospitals [ll], and beta-lactamase produc- 
tion and glycopeptide resistance are also being 
encountered in this pathogen. More frequent isola- 
tion of aminoglycoside-resistant gram-negative 
pathogens was hinted at in the review of data from 
the 1970s [6] and a similar problem with the new 
extended spectrum beta-lactams is apparent from 
the limited data presented here. Overall, the re- 
markable ability of nosocomial bacterial pathogens 
to persist in the hospital environment despite new 
therapies continues to present important chal- 
lenges to infection control. More than ever, preven- 
tion rather than treatment after occurrence of 
nosocomial infection should remain a primary 
goal. 
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